Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_assertion type Assertion NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_head.
- NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_assertion wasGeneratedBy ECO_0000203 NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_provenance.
- NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_assertion wasDerivedFrom befree-20140225 NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_provenance.
- NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_assertion SIO_000772 23165859 NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_provenance.
- NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_assertion evidence source_evidence_literature NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_provenance.
- NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_assertion description "[The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166835.RAbwVDlkcAN7AN1nI9ccvWNmbiVuIukLN94wKo-B9i7K4130_provenance.